These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2860917)

  • 1. The role of clinical pharmacology in the development and evaluation of oral controlled-release dosage forms.
    Kendall MJ; John VA
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):65S-67S. PubMed ID: 2860917
    [No Abstract]   [Full Text] [Related]  

  • 2. Slow release beta-adrenoceptor blocking drugs.
    Harron DW; Howe A; Shanks RG
    J R Coll Physicians Lond; 1983 Apr; 17(2):126-32. PubMed ID: 6132994
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of angina pectoris with beta-receptor blocking agents. Effects of long-term treatment and treatment with sustained release tablets.
    Björntorp P
    Acta Med Scand; 1971 Apr; 189(4):299-301. PubMed ID: 4398906
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 5. Mononitrates in combination with beta-blocker therapy in the treatment of severe angina pectoris.
    Svendsen JH; Amtorp O
    Drugs; 1987; 33 Suppl 4():122-4. PubMed ID: 2887420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of long-acting anti-anginal drugs in the treatment of cardiovascular diseases].
    Watanabe H; Kato K
    Kokyu To Junkan; 1990 Nov; 38(11):1081-9. PubMed ID: 1979885
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current problems of treating ischemic heart disease in the polyclinic].
    Pomerantsev VP
    Sov Med; 1982; (5):75-9. PubMed ID: 6126010
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
    Ermilov LP; Kuleshova EV; Treshkur TV; Andreeva IV
    Klin Med (Mosk); 1980 Apr; 58(4):77-81. PubMed ID: 6103973
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for angina pectoris.
    Drug Ther Bull; 1974 Jan; 12(1):1-2. PubMed ID: 4150248
    [No Abstract]   [Full Text] [Related]  

  • 10. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
    Gunasekara NS; Noble S
    Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitrite therapy of stenocardia].
    Meesmann W; Amann L
    Dtsch Med Wochenschr; 1971 Sep; 96(36):1444-9. PubMed ID: 4397998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta blockers in stable angina pectoris].
    Fluri M; Meier B
    Praxis (Bern 1994); 1995 Mar; 84(10):288-95. PubMed ID: 7892549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
    Uusitalo A
    Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of beta receptor blockers in angina pectoris].
    Bodem G; Ochs HR
    Dtsch Med Wochenschr; 1979 Jan; 104(1):6-9. PubMed ID: 32023
    [No Abstract]   [Full Text] [Related]  

  • 16. The medical management of angina pectoris.
    Paul O
    JAMA; 1977 Oct; 238(17):1847-8. PubMed ID: 20519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris.
    Packer M
    N Engl J Med; 1989 Mar; 320(11):709-18. PubMed ID: 2564164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current state and goals of the clinico-pharmacological evaluation of anti-arrhythmia and anti-angina agents].
    Mazur NA
    Kardiologiia; 1982 May; 22(5):42-7. PubMed ID: 6124650
    [No Abstract]   [Full Text] [Related]  

  • 19. [Discontinuation of beta blockers in patients with angina pectoris].
    Rangno RE
    Internist (Berl); 1983 Jan; 24(1):55-8. PubMed ID: 6132895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenergic beta-blockade in angina pectoris. A study of the effects of Practolol (Eraldin, I.C.I. 50172) with special attention to the matter of dosage].
    Christensen E; Busch M
    Ugeskr Laeger; 1971 Feb; 133(7):296-9. PubMed ID: 4396025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.